✦ LIBER ✦

Development and use of FRAX® in osteoporosis

✍ Scribed by J. A. Kanis; E. V. McCloskey; H. Johansson; A. Oden; O. Ström; F. Borgström

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Interpretation and use of FRAX in clinic

✍ J. A. Kanis; D. Hans; C. Cooper; S. Baim; J. P. Bilezikian; N. Binkley; J. A. Ca 📂 Article 📅 2011 🏛 Springer-Verlag 🌐 English ⚖ 486 KB

The cost-effectiveness of risedronate in

✍ F. Borgström; O. Ström; J. Coelho; H. Johansson; A. Oden; E. V. McCloskey; J. A. 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 216 KB

Clinical Risk Factors for Osteoporosis i

✍ N. M. Cummins; E. K. Poku; M. R. Towler; O. M. O’Driscoll; S. H. Ralston 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 219 KB

History and development of bisphosphonat

✍ C. Chesnut 📂 Article 📅 1996 🏛 Springer-Verlag 🌐 English ⚖ 99 KB

Use of intravenous bisphosphonates in os

✍ Roberto Civitelli; Nicola Napoli; Reina Armamento-Villareal 📂 Article 📅 2007 🏛 Current Science Inc. 🌐 English ⚖ 918 KB

Case finding for the management of osteo

✍ J. A. Kanis; E. V. McCloskey; H. Johansson; O. Strom; F. Borgstrom; A. Oden; Nat 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 309 KB